Study identifies brain protein that could put the brakes on Alzheimer's

Study identifies brain protein that could put the brakes on Alzheimer’s
Alessandra Martini and Frank LaFerla the UCI School of Biological Sciences led the study. Credit: UCI

University of California, Irvine biologists blazing new approaches to studying Alzheimer's disease have made a major finding on combating inflammation linked to the disease. The School of Biological Sciences researchers' discovery about the role of a protein called TOM-1 heralds a shift toward examining the molecular underpinnings of Alzheimer's processes.

Their study appears in the Proceedings of the National Academy of Sciences.

"Scientists have known for a long time that inflammation is a driver of Alzheimer's , but inflammation is complex and involves many factors," said School of Biological Sciences Dean Frank LaFerla, Ph.D., whose laboratory conducted the research. "That's why we decided to look at TOM-1.

The protein helps to regulate a key component of the inflammatory response. "We were interested in TOM-1 because its levels are low in the Alzheimer's brain and in the brains of Alzheimer's rodent models," said Alessandra Martini, Ph.D., the paper's first author and a postdoctoral researcher who worked with LaFerla. "However, its specific role in the disease has largely been unexplored."

The scientists discovered that reducing the amount of TOM-1 in Alzheimer's rodent models increased pathology, which included increased , and exacerbated cognitive problems associated with the disease. Restoring TOM-1 levels reversed those effects.

"You can think of TOM-1 as being like the brakes of a car, and the brakes aren't working for people with Alzheimer's," LaFerla said. "This research shows that fixing the brakes at the could provide an entirely new therapeutic avenue. With millions of people affected by Alzheimers and the numbers growing, we must research a diverse portfolio of approaches so we can one day vanquish this terrible disease."


Explore further

Potential target for diabetes-associated Alzheimer's disease

More information: Alessandra Cadete Martini et al. Amyloid-beta impairs TOM1-mediated IL-1R1 signaling, Proceedings of the National Academy of Sciences (2019). DOI: 10.1073/pnas.1914088116
Citation: Study identifies brain protein that could put the brakes on Alzheimer's (2019, October 1) retrieved 14 October 2019 from https://medicalxpress.com/news/2019-10-brain-protein-alzheimer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
6046 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more